United States - English - NLM (National Library of Medicine)

b. braun medical inc. - water (unii: 059qf0ko0r) (water - unii:059qf0ko0r) - water 1 ml in 1 ml - sterile water for injection usp is indicated for use in adults and pediatric patients as a diluent in the aseptic preparation of parenteral solutions or as a vehicle for drug administration after admixture or dilution. none known.

United States - English - NLM (National Library of Medicine)

american regent, inc. - water (unii: 059qf0ko0r) (water - unii:059qf0ko0r) - water 1 ml in 1 ml - sterile water for injection, usp is water for injection sterilized and packaged in single dose vials. it contains no antimicrobial agents or other preservatives. it is used as a diluent. non-pyrogenic.

United States - English - NLM (National Library of Medicine)

hospira, inc. - water (unii: 059qf0ko0r) (water - unii:059qf0ko0r) - water 1 ml in 1 ml - this parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered. sterile water for injection, usp must be made approximately isotonic prior to use.

United States - English - NLM (National Library of Medicine)

sperian eye & face protection inc - water (unii: 059qf0ko0r) (water - unii:059qf0ko0r) - water 99 ml in 100 ml - flushing agent for flushing the eye to reduce the chance of severe injury caused by acid, alkali, or particulate contamination.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - water (unii: 059qf0ko0r) (water - unii:059qf0ko0r) - water 1000 ml in 1000 ml - sterile water for injection is indicated for use only as a solvent or diluent vehicle for parenterally administered drugs or solutions and as a source of water for parenteral fluid replenishment after suitable additives are introduced. for intravenous administration, an osmolar concentration not less than two-fifths (0.4) of the normal osmolarity of the extracellular fluid (280 mosmol/liter) is essential to avoid intravascular hemolysis. do not administer without the addition of a solute. check flexible container solution composition, lot number, and expiry date. do not remove solution container from its overwrap until immediately before use. use sterile equipment and aseptic technique. to open - turn solution container over so that the text is face down.  using the pre-cut corner tabs, peel open the overwrap and remove solution container. - check the solution container for leaks by squeezing firmly.  if leaks are found, or if the seal is not intact, discard the solution. - do not use if the solution is cloud

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - soya oil, quantity: 200 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; egg lecithin; glycerol; water for injections - indications: part of the intravenous diet in all parenteral nutrition indications including:- 1. preoperative and postoperative nutritional disturbances where an improved nitrogen balance is required; 2. nutritional disorders or disturbances of nitrogen balance due to inadequate or failing intestinal absorption caused by tumours in the gastrointestinal tract, acute or chronic intestinal diseases (peritonitis, ulcerative colitis, terminal ileitis); 3. burns, to reduce the frequently-excessive nitrogen losses; 4. prolonged unconsciousness, eg. following cranial trauma or poisoning in cases where enteral feeding is inappropriate or impossible; 5.impaired renal function where a concentrated source of energy may be indicated to reduce protein breakdown; 6. cachexia; 7. patients with essential fatty acid deficiency who cannot maintain or restore a normal essential fatty acid pattern by oral intake.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - soya oil, quantity: 100 g/l - injection, intravenous infusion - excipient ingredients: water for injections; glycerol; egg lecithin; sodium hydroxide - indications: part of the intravenous diet in all parenteral nutrition indications including:- 1. preoperative and postoperative nutritional disturbances where an improved nitrogen balance is required; 2. nutritional disorders or disturbances of nitrogen balance due to inadequate or failing intestinal absorption caused by tumours in the gastrointestinal tract, acute or chronic intestinal diseases (peritonitis, ulcerative colitis, terminal ileitis); 3. burns, to reduce the frequently-excessive nitrogen losses; 4. prolonged unconsciousness, eg. following cranial trauma or poisoning in cases where enteral feeding is inappropriate or impossible; 5.impaired renal function where a concentrated source of energy may be indicated to reduce protein breakdown; 6. cachexia; 7. patients with essential fatty acid deficiency who cannot maintain or restore a normal essential fatty acid pattern by oral intake.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 37.5 g/l; sodium chloride, quantity: 2.25 g/l; potassium chloride, quantity: 1.5 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the potassium chloride ( 0.15%) and sodium chloride (0.225 %) and glucose (3.75 %) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 500 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 50 g/l - injection, solution - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)